About Bill Loo
Bill Loo co-founded TibaRay, which is developing compact linear accelerators for FLASH radiotherapy, and serves as its chief medical advisor and a board member. He is a physician-scientist in radiation oncology and bioengineering at Stanford Cancer Institute. There he directs the thoracic radiation oncology program, co-directs particle therapy, and leads new technology development in radiation oncology. His clinical work focuses on radiation therapy for lung and thoracic cancers, including stereotactic ablative radiotherapy and four-dimensional image-guided radiation therapy.
He is principal investigator of a research lab that studies the biology of ultra-rapid FLASH radiotherapy and develops new radiation technologies. He conceived the PHASER concept for FLASH cancer therapy and co-leads its research and development. He also serves on National Comprehensive Cancer Network panels that write widely used cancer treatment guidelines.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Bill Loo in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Bill Loo works with at each company, as listed on that company's latest Form D.
